UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027230 |
|---|---|
| Receipt number | R000031200 |
| Scientific Title | Efficacy and safety of laparoscopic radical hysterectomy for patients with early-stage uterine cervical cancer |
| Date of disclosure of the study information | 2017/05/02 |
| Last modified on | 2017/05/02 22:29:15 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy and safety of laparoscopic radical hysterectomy for patients with early-stage uterine cervical cancer
Acronym
Efficacy and safety of laparoscopic radical hysterectomy for patients with early-stage uterine cervical cancer
Scientific Title
Efficacy and safety of laparoscopic radical hysterectomy for patients with early-stage uterine cervical cancer
Scientific Title:Acronym
Efficacy and safety of laparoscopic radical hysterectomy for patients with early-stage uterine cervical cancer
Region
| Japan |
Condition
Condition
cervical cancer
Classification by specialty
| Obstetrics and Gynecology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate efficacy and safety of laparoscopic radical hysterectomy for cervical cancer
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Pathological evaluation of surgical completion
Key secondary outcomes
Surgical adverse effect(blood loss, blood transfusion, postoperative complications)
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
Laparoscopic radical hysterectomy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
1)International Federation of Gynec ology and Obstetrics (FIGO) stage of IA 2, IB1, or IIA1
2)Age of over 20 years
3)Those with adequate organ function
4)Those who have given written informed consent
Key exclusion criteria
1)Tumor diameter>40mm
2)Those with serious complication
3)Those with concomitant active malignancy
4)Those who are inadequate to be enrolled in the protocol study by the investigator
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hideto Katayama |
Organization
Asahikawa Medical University
Division name
Department of Obstetrics and Gynecology
Zip code
Address
Midorigaoka Higashi 2-1-1-1,Asahikawa,Japan
TEL
0166-65-2111
kyama@asahikawa-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hideto Katayama |
Organization
Asahikawa Medical University
Division name
Department of Obstetrics and Gynecology
Zip code
Address
Midorigaoka Higashi 2-1-1-1,Asahikawa,Japan
TEL
0166-65-2111
Homepage URL
kyama@asahikawa-med.ac.jp
Sponsor or person
Institute
Asahikawa Medical University Hospital
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 05 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2016 | Year | 03 | Month | 10 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 05 | Month | 02 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 05 | Month | 02 | Day |
Last modified on
| 2017 | Year | 05 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031200
